Multibagger Stock Under Rs 150 Delivered Over 500% Returns: Sampre Nutrition’s Net Profit Jumps Over 6x and Revenue Up 37.5% in Q2FY26

DSIJ Intelligence-2 / 07 Nov 2025/ Categories: Mindshare, Multibaggers, Trending

Multibagger Stock Under Rs 150 Delivered Over 500% Returns: Sampre Nutrition’s Net Profit Jumps Over 6x and Revenue Up 37.5% in Q2FY26

On Friday, Sampre Nutrition’s share price hit a 2 per cent lower circuit at Rs 138.60, after previously recording 90 consecutive upper circuits and delivering over 550 per cent returns in a year.

Sampre Nutritions Limited, a confectionery and nutraceutical manufacturer, reported strong Q2FY26 results. Revenue from operations rose 37.5 per cent year-on-year to Rs 9.99 crore from Rs 7.27 crore in Q2FY25. Net profit surged over six times to Rs 89.55 lakh compared to Rs 12.45 lakh in the same period last year, marking a 620 per cent growth. For H1FY26, revenue increased 77 per cent to Rs 20.86 crore from Rs 11.78 crore, while net profit rose to Rs 160.41 lakh against Rs 22.34 lakh in H1FY25.

On November 5, 2025, the Board of Directors approved the allotment of 17.70 lakh equity shares of Rs 5 face value each at Rs 42 per share to promoters Mr. Brahma Gurbani and Ms. Meera Gurbani by converting unsecured loans worth Rs 7.43 crore. The issue price of Rs 42 per share, adjusted for stock split and bonus, stands above the current market price of Rs 35.35 per share.

Sampre also entered into a manufacturing agreement with Reliance Consumer Products Ltd. (RCPL) to produce nutraceutical and food products, estimated to generate business worth Rs 12–15 crore annually over three years. The company will manufacture confectionery items such as hard-boiled candies, lollIPOps, and toffees under RCPL’s quality standards.

The company approved the issuance of Foreign Currency Convertible Bonds (FCCBs) worth USD 4 crore (Rs 355.06 crore) through 400 FCCBs of USD 1 lakh each. The proceeds will support expansion in emerging markets like Egypt and Liberia. Aries Capital Limited will serve as the Lead Arranger, and the FCCBs were made available on the AFRINEX Exchange, Mauritius, between October 10 and October 15, 2025.

Additionally, in August 2025, Sampre signed a manufacturing agreement with Tolaram Wellness Ltd., Nigeria, expected to generate Rs 10 crore annually for three years. Another agreement with Rama Exports, signed on August 19, 2025, is projected to bring in Rs 15 crore over three years, enhancing its export operations.

Sampre Nutritions was also recognized under the India 5000 Best MSME Awards 2024 for excellence in quality, customer satisfaction, and societal impact.

On Friday, Sampre Nutrition’s share price hit a 2 per cent Lower Circuit at Rs 138.60, after previously recording 90 consecutive Upper Circuits and delivering over 550 per cent returns in a year.

Disclaimer: The article is for informational purposes only and not investment advice.